ClinicalTrials.Veeva

Menu

Enhancing Hair Density With Platelet Rich Fibrin Matrix (PRFM)

T

The New York Eye & Ear Infirmary

Status and phase

Completed
Phase 3

Conditions

Alopecia

Treatments

Biological: PRFM treatment

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Clinical alopecia occurs due to miniaturization of the hair shafts as well as loss of active production of hair shafts. PRFM has been shown to induce dermal angiogenesis, and anecdotal findings of improvement of hair appearance after PRFM injection in the scalp suggest that PRFM may play a role in the treatment of thinning hair. Patients will be treated on a monthly basis with intradermal injections of autologous PRFM for 3 months. Changes in hair density will be assessed by comparing pre- and post-treatment photographs and non-invasive measurements of hair density at 1, 2, 3, 4 and 6 months after initial treatment.

Enrollment

15 patients

Sex

All

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age 18- 75 years old
  • frontal and/or crown alopecia

Exclusion criteria

  • bleeding disorder

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Treatment with PRFM
Experimental group
Description:
Subjects treated monthly 3 times with intradermal injections of PRFM into bald/balding scalp. Post-treatment hair density index measured and compared to hair density index measured prior to treatment for each subject.
Treatment:
Biological: PRFM treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems